Taisho Pharmaceutical Indonesia Tbk PT - ESG Rating & Company Profile powered by AI
Browse to the bottom of the page for potential risks for Taisho Pharmaceutical Indonesia Tbk PT based on industry, location and size. This ESG score covers 17 United Nations Sustainable Development Goals including: 'Gender Equality', 'Decent Work & Economic Growth' and 'Life on Land'. This ESG assessment for Taisho Pharmaceutical Indonesia Tbk PT indicates the company's reporting of the UN SDGs.
Taisho Pharmaceutical Indonesia Tbk PT in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 8.0, social score of 0.0 and governance score of 0.0.
2.7
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1393 | Vaccinex Inc | 2.8 | Medium |
1393 | YSP Southeast Asia Holding Bhd | 2.8 | Medium |
1437 | Taisho Pharmaceutical Indonesia Tbk PT | 2.7 | Medium |
1437 | CanadaBis Capital Inc | 2.7 | Medium |
1437 | Cannabics Pharmaceuticals Inc | 2.7 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Taisho Pharmaceutical Indonesia Tbk PT have an accelerator or VC vehicle to help deliver innovation?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose current and historical energy intensity?
Does Taisho Pharmaceutical Indonesia Tbk PT report the average age of the workforce?
Does Taisho Pharmaceutical Indonesia Tbk PT reference operational or capital allocation in relation to climate change?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose its ethnicity pay gap?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose cybersecurity risks?
Does Taisho Pharmaceutical Indonesia Tbk PT offer flexible work?
Does Taisho Pharmaceutical Indonesia Tbk PT have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose the number of employees in R&D functions?
Does Taisho Pharmaceutical Indonesia Tbk PT conduct supply chain audits?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Taisho Pharmaceutical Indonesia Tbk PT conduct 360 degree staff reviews?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose the individual responsible for D&I?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose current and / or historical scope 2 emissions?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose water use targets?
Does Taisho Pharmaceutical Indonesia Tbk PT have careers partnerships with academic institutions?
Did Taisho Pharmaceutical Indonesia Tbk PT have a product recall in the last two years?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose incidents of discrimination?
Does Taisho Pharmaceutical Indonesia Tbk PT allow for Work Councils/Collective Agreements to be formed?
Has Taisho Pharmaceutical Indonesia Tbk PT issued a profit warning in the past 24 months?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose parental leave metrics?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose climate scenario or pathway analysis?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose the pay ratio of women to men?
Does Taisho Pharmaceutical Indonesia Tbk PT support suppliers with sustainability related research and development?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Taisho Pharmaceutical Indonesia Tbk PT reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Taisho Pharmaceutical Indonesia Tbk PT involved in embryonic stem cell research?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose GHG and Air Emissions intensity?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose its waste policy?
Does Taisho Pharmaceutical Indonesia Tbk PT report according to TCFD requirements?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose energy use targets?
Does Taisho Pharmaceutical Indonesia Tbk PT disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Taisho Pharmaceutical Indonesia Tbk PT have a policy relating to cyber security?
Have a different question?
Potential Risks for Taisho Pharmaceutical Indonesia Tbk PT
These potential risks are based on the size, segment and geographies of the company.